Libris Innovations, the for-profit subsidiary of the Indiana Biosciences Research Institute (IBRI), is pleased to announce the appointment of Ramani Varanasi as Chief Executive Officer. In...
High-Throughput Single B-Cell Screening Platform Now Available for Purchase by OmniAb’s Partners for Use in Their Own Laboratories OmniAb, Inc. (NASDAQ: OABI) today introduced the launch...
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced the...